{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:32:41Z","timestamp":1793302361129,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Changsha Natural Science Foundation","award":["kq2403053"],"award-info":[{"award-number":["kq2403053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      This study explored the impact of vaginal microbes, metabolites, and\n                      <jats:italic>METTL1<\/jats:italic>\n                      -mediated m7G modification of\n                      <jats:italic>BRCA1<\/jats:italic>\n                      mRNA on High-Grade Serous Ovarian Cancer (HGSOC).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>METTL1<\/jats:italic>\n                      and\n                      <jats:italic>BRCA1<\/jats:italic>\n                      expression levels were assessed via bioinformatics, Western blotting, and RT-qPCR. Their interaction was studied using RNA co-immunoprecipitation and RNA pull-down assays. The functions and mechanisms of\n                      <jats:italic>METTL1<\/jats:italic>\n                      and\n                      <jats:italic>BRCA1<\/jats:italic>\n                      in HGSOC were investigated through CCK-8 assays, flow cytometry, transwell migration assays, and nude mouse xenograft models. We analyzed vaginal microbial and metabolite differences in HGSOC patients with varying\n                      <jats:italic>BRCA1<\/jats:italic>\n                      expression using 16\u00a0S rRNA sequencing and liquid chromatography. Associations were evaluated with Spearman correlation and heat maps, while molecular docking assessed key metabolite binding to\n                      <jats:italic>METTL1<\/jats:italic>\n                      . The roles and interactions of selected metabolites with\n                      <jats:italic>METTL1\/BRCA1<\/jats:italic>\n                      in HGSOC were validated through in vivo and in vitro experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In HGSOC, both\n                      <jats:italic>METTL1<\/jats:italic>\n                      and\n                      <jats:italic>BRCA1<\/jats:italic>\n                      were up-regulated.\n                      <jats:italic>METTL1<\/jats:italic>\n                      enhanced\n                      <jats:italic>BRCA1<\/jats:italic>\n                      expression via m7G modification, boosting cell proliferation and tumor growth. Elevated\n                      <jats:italic>BRCA1<\/jats:italic>\n                      levels were associated with changes in vaginal microbiota, particularly increased Lactobacillus, and alterations in metabolic pathways. Correlation analysis indicated that Lactobacillus was significantly negatively correlated with 5-formamidoimidazole-4-carboxamide ribotide, inosine, cobalt-precorrin-7, and uridine, but positively correlated with L-lysine. The strongest correlation was with 5-formamidoimidazole-4-carboxamide ribotide. Molecular docking showed that this compound binds strongly to\n                      <jats:italic>METTL1<\/jats:italic>\n                      . Functional tests demonstrated that it inhibits HGSOC cell proliferation and tumor growth by disrupting\n                      <jats:italic>METTL1<\/jats:italic>\n                      -mediated m7G modification of\n                      <jats:italic>BRCA1<\/jats:italic>\n                      . Overexpression of\n                      <jats:italic>METTL1<\/jats:italic>\n                      or\n                      <jats:italic>BRCA1<\/jats:italic>\n                      negated its anti-tumor effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The vaginal microbial metabolite 5-formamidoimidazole-4-carboxamide ribotide reduces\n                      <jats:italic>BRCA1<\/jats:italic>\n                      expression and slows HGSOC progression by modifying\n                      <jats:italic>BRCA1<\/jats:italic>\n                      m7G through\n                      <jats:italic>METTL1<\/jats:italic>\n                      , suggesting its potential as an HGSOC treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-025-01396-y","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:56:47Z","timestamp":1766397407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Microbial metabolite 5-formamidoimidazole-4-carboxamide ribotide targets METTL1 to inhibit m7G modification of BRCA1 mRNA to inhibit high-grade serous ovarian cancer"],"prefix":"10.1186","volume":"32","author":[{"given":"Lixing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5738-8803","authenticated-orcid":false,"given":"Sili","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"1396_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147891","author":"RH AlMalki","year":"2024","unstructured":"AlMalki RH, et al. Comparative analysis of breast cancer metabolomes highlights Fascin\u2019s central role in regulating key pathways related to disease progression. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25147891.","journal-title":"Int J Mol Sci"},{"key":"1396_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1471-0528.15981","volume":"127","author":"JC Borgogna","year":"2020","unstructured":"Borgogna JC, et al. The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis. BJOG. 2020;127:182\u201392.","journal-title":"BJOG"},{"key":"1396_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.886170","volume":"13","author":"NT Bound","year":"2022","unstructured":"Bound NT, Vandenberg CJ, Kartikasari AER, Plebanski M, Scott CL. Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: a focus on the immune system. Front Genet. 2022;13:886170.","journal-title":"Front Genet"},{"key":"1396_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2031500","volume":"11","author":"M Bourgin","year":"2022","unstructured":"Bourgin M, Kepp O, Kroemer G. Immunostimulatory effects of vitamin B5 improve anticancer immunotherapy. Oncoimmunology. 2022;11:2031500.","journal-title":"Oncoimmunology"},{"key":"1396_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.5582\/bst.2023.01133","volume":"17","author":"W Cao","year":"2024","unstructured":"Cao W, et al. The effect of the female genital tract and gut Microbiome on reproductive dysfunction. Biosci Trends. 2024;17:458\u201374.","journal-title":"Biosci Trends"},{"key":"1396_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1044-579X(02)00056-1","volume":"12","author":"A Catteau","year":"2002","unstructured":"Catteau A, Morris JR. BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol. 2002;12:359\u201371.","journal-title":"Semin Cancer Biol"},{"key":"1396_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-2-23","volume":"2","author":"B Chaban","year":"2014","unstructured":"Chaban B, et al. Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome. 2014;2:23.","journal-title":"Microbiome"},{"key":"1396_CR8","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1158\/0008-5472.CAN-21-0106","volume":"81","author":"L Chen","year":"2021","unstructured":"Chen L, et al. Altering the microbiome inhibits tumorigenesis in a mouse model of oviductal high-grade serous carcinoma. Cancer Res. 2021;81:3309\u201318.","journal-title":"Cancer Res"},{"key":"1396_CR9","doi-asserted-by":"crossref","unstructured":"Cruz-Collazo AM et al. Novel inhibition of central carbon metabolism pathways by Rac and Cdc42 inhibitor MBQ-167 and Paclitaxel. Mol Cancer Ther. 2024;23:1613\u201325.","DOI":"10.1158\/1535-7163.MCT-23-0803"},{"key":"1396_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2406748121","volume":"121","author":"A Dahal","year":"2024","unstructured":"Dahal A, et al. Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. Proc Natl Acad Sci U S A. 2024;121:e2406748121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1396_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09842-6","volume":"7","author":"M Di Paola","year":"2017","unstructured":"Di Paola M, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. Sci Rep. 2017;7:10200.","journal-title":"Sci Rep"},{"key":"1396_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10096-016-2768-8","volume":"36","author":"G Donders","year":"2017","unstructured":"Donders G, et al. Influence of contraceptive choice on vaginal bacterial and fungal microflora. Eur J Clin Microbiol Infect Dis. 2017;36:43\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1396_CR13","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.12659\/MSM.904789","volume":"23","author":"LF Dong","year":"2017","unstructured":"Dong LF, Xu SY, Long JP, Wan F, Chen YD. RNA-sequence analysis reveals differentially expressed genes (DEGs) in patients exhibiting different risks of tumor metastasis. Med Sci Monit. 2017;23:2842\u20139.","journal-title":"Med Sci Monit"},{"key":"1396_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111145","volume":"118","author":"R Dong","year":"2024","unstructured":"Dong R, et al. WDR4 promotes HCC pathogenesis through N(7)-methylguanosine by regulating and interacting with METTL1. Cell Signal. 2024;118:111145.","journal-title":"Cell Signal"},{"key":"1396_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/path.5661","volume":"254","author":"P Gonz\u00e1lez-S\u00e1nchez","year":"2021","unstructured":"Gonz\u00e1lez-S\u00e1nchez P, DeNicola GM. The microbiome(s) and cancer: know thy neighbor(s). J Pathol. 2021;254:332\u201343.","journal-title":"J Pathol"},{"key":"1396_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158304","author":"P Gralewska","year":"2024","unstructured":"Gralewska P, Gajek A, Marczak A, Rogalska A. Targeted nanocarrier-based drug delivery strategies for improving the therapeutic efficacy of PARP inhibitors against ovarian cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25158304.","journal-title":"Int J Mol Sci"},{"key":"1396_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1390116","volume":"15","author":"F Guffanti","year":"2024","unstructured":"Guffanti F, et al. BRCA1 foci test as a predictive biomarker of Olaparib response in ovarian cancer patient-derived xenograft models. Front Pharmacol. 2024;15:1390116.","journal-title":"Front Pharmacol"},{"key":"1396_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00514-w","volume":"19","author":"Z Guo","year":"2024","unstructured":"Guo Z, et al. Reprogramming hematopoietic stem cell metabolism in lung cancer: glycolysis, oxidative phosphorylation, and the role of 2-DG. Biol Direct. 2024;19:73.","journal-title":"Biol Direct"},{"key":"1396_CR19","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.7150\/ijbs.90382","volume":"20","author":"M Han","year":"2024","unstructured":"Han M, et al. M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets. Int J Biol Sci. 2024a;20:1238\u201355.","journal-title":"Int J Biol Sci"},{"key":"1396_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69789-3","volume":"14","author":"B Han","year":"2024","unstructured":"Han B, et al. Peptidomic analysis reveals novel peptide PDLC promotes cell proliferation in hepatocellular carcinoma via Ras\/Raf\/MEK\/ERK pathway. Sci Rep. 2024b;14:18757.","journal-title":"Sci Rep"},{"key":"1396_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, et al. Tryptophan-derived microbial metabolites activate the Aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55:324\u2013e340328.","journal-title":"Immunity"},{"key":"1396_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ygyno.2007.07.072","volume":"107","author":"NS Horowitz","year":"2007","unstructured":"Horowitz NS, et al. Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis. Gynecol Oncol. 2007;107:344\u20139.","journal-title":"Gynecol Oncol"},{"key":"1396_CR23","doi-asserted-by":"crossref","unstructured":"Human Microbiome Project Consortium. Structure, function and diversity of the healthy human Microbiome. Nature. 2012;486:207\u201314.","DOI":"10.1038\/nature11234"},{"key":"1396_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ebiom.2019.04.028","volume":"44","author":"ZE Ilhan","year":"2019","unstructured":"Ilhan ZE, et al. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019;44:675\u201390.","journal-title":"EBioMedicine"},{"key":"1396_CR25","unstructured":"Izabela L et al. Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1\/2 mutation status. Breast Cancer Res Treat. 2024."},{"key":"1396_CR26","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.4149\/neo_2021_210226N256","volume":"68","author":"K Jan\u00edkov\u00e1","year":"2021","unstructured":"Jan\u00edkov\u00e1 K, et al. High-grade serous ovarian carcinoma and detection of inactivated BRCA genes from biopsy material of Slovak patients. Neoplasma. 2021;68:1107\u201312.","journal-title":"Neoplasma"},{"key":"1396_CR27","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/jnci\/djaa070","volume":"112","author":"RD Kalachand","year":"2020","unstructured":"Kalachand RD, et al. BRCA1 promoter methylation and clinical outcomes in ovarian cancer: an individual patient data meta-analysis. J Natl Cancer Inst. 2020;112:1190\u2013203.","journal-title":"J Natl Cancer Inst"},{"key":"1396_CR28","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/s41591-019-0612-2","volume":"25","author":"JW Kim","year":"2019","unstructured":"Kim JW, et al. Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma. Nat Med. 2019;25:1783\u201395.","journal-title":"Nat Med"},{"key":"1396_CR29","doi-asserted-by":"crossref","unstructured":"Kooshan Z, C\u00e1rdenas-Piedra L, Clements J, Batra J. Glycolysis, the sweet appetite of the tumour microenvironment. Cancer Lett. 2024;600:217156.","DOI":"10.1016\/j.canlet.2024.217156"},{"issue":"3","key":"1396_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34(3):433\u201343.","journal-title":"Am J Surg Pathol"},{"key":"1396_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-023-03760-y","volume":"23","author":"Q Lan","year":"2023","unstructured":"Lan Q, Zhang C, Hua H, Hu X. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study. BMC Oral Health. 2023;23:1021.","journal-title":"BMC Oral Health"},{"key":"1396_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI181062","author":"X Li","year":"2024","unstructured":"Li X, Zou L. BRCAness, DNA gaps, and gain and loss of PARP inhibitor-induced synthetic lethality. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI181062.","journal-title":"J Clin Invest"},{"key":"1396_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28898","volume":"95","author":"C Li","year":"2023","unstructured":"Li C, et al. Association between vaginal microbiota and the progression of ovarian cancer. J Med Virol. 2023;95:e28898.","journal-title":"J Med Virol"},{"key":"1396_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41564-021-01030-7","volume":"7","author":"NN Liu","year":"2022","unstructured":"Liu NN, et al. Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts. Nat Microbiol. 2022;7:238\u201350.","journal-title":"Nat Microbiol"},{"key":"1396_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122891","volume":"352","author":"Q Liu","year":"2024","unstructured":"Liu Q. 2\u2032, 3\u2032, 5\u2032-tri-O-acetyl-N6-(3-hydroxyphenyl) adenosine alleviates diet-induced hyperlipidemia by modulating intestinal gene expression profiles and metabolic pathway. Life Sci. 2024;352:122891.","journal-title":"Life Sci"},{"key":"1396_CR36","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1001\/jamaoncol.2022.3846","volume":"8","author":"PE L\u00f8nning","year":"2022","unstructured":"L\u00f8nning PE, et al. Constitutional BRCA1 methylation and risk of incident triple-negative breast cancer and high-grade serous ovarian cancer. JAMA Oncol. 2022;8:1579\u201387.","journal-title":"JAMA Oncol"},{"key":"1396_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01746","volume":"10","author":"G Mori","year":"2019","unstructured":"Mori G, et al. Gut microbiota analysis in postoperative Lynch syndrome patients. Front Microbiol. 2019;10:1746.","journal-title":"Front Microbiol"},{"key":"1396_CR38","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S1470-2045(19)30340-7","volume":"20","author":"NR Nen\u00e9","year":"2019","unstructured":"Nen\u00e9 NR, et al. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. Lancet Oncol. 2019;20:1171\u201382.","journal-title":"Lancet Oncol"},{"key":"1396_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02048-1","volume":"23","author":"K Nesic","year":"2024","unstructured":"Nesic K, et al. BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. Mol Cancer. 2024;23:158.","journal-title":"Mol Cancer"},{"key":"1396_CR40","doi-asserted-by":"crossref","unstructured":"Pant A et al. The CCR6-CCL20 axis promotes regulatory T cell Glycolysis and immunosuppression in tumors. Cancer Immunol Res. 2024.","DOI":"10.1158\/2326-6066.c.7522952"},{"key":"1396_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009058","author":"J Park","year":"2024","unstructured":"Park J, et al. Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8(+) TILs based on BRCA1\/2 mutation status in epithelial ovarian cancers. J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2024-009058.","journal-title":"J Immunother Cancer"},{"key":"1396_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1334502","volume":"15","author":"A Peremykina","year":"2024","unstructured":"Peremykina A, et al. Microbiome markers in HPV-positive and HPV-negative women of reproductive age with ASCUS and SIL determined by V4 region of 16S rRNA gene sequencing. Front Microbiol. 2024;15:1334502.","journal-title":"Front Microbiol"},{"key":"1396_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.61186\/ibj.3846","volume":"27","author":"S Pourmollaei","year":"2023","unstructured":"Pourmollaei S, et al. Anticancer effect of Enterococcus faecium, isolated from vaginal fluid, on ovarian cancer cells. Iran Biomed J. 2023;27:205\u201313.","journal-title":"Iran Biomed J"},{"issue":"Suppl 1","key":"1396_CR44","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel J, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4680\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1396_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54401-w","volume":"9","author":"HD Reyes","year":"2019","unstructured":"Reyes HD, et al. Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior. Sci Rep. 2019;9:17996.","journal-title":"Sci Rep"},{"key":"1396_CR46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-022-05565-5","volume":"613","author":"VM Ruiz-Arroyo","year":"2023","unstructured":"Ruiz-Arroyo VM, et al. Structures and mechanisms of tRNA methylation by METTL1-WDR4. Nature. 2023;613:383\u201390.","journal-title":"Nature"},{"key":"1396_CR47","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1016\/j.ejca.2014.05.001","volume":"50","author":"I Ruscito","year":"2014","unstructured":"Ruscito I, et al. BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients\u2013a study of the tumour bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD). Eur J Cancer. 2014;50:2090\u20138.","journal-title":"Eur J Cancer"},{"key":"1396_CR48","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.devcel.2023.04.012","volume":"58","author":"W Senkowski","year":"2023","unstructured":"Senkowski W, et al. A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids. Dev Cell. 2023;58:1106\u2013e11211107.","journal-title":"Dev Cell"},{"key":"1396_CR49","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/mi.2016.129","volume":"10","author":"B Shannon","year":"2017","unstructured":"Shannon B, et al. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. Mucosal Immunol. 2017;10:1310\u20139.","journal-title":"Mucosal Immunol"},{"key":"1396_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00948","volume":"9","author":"P Sharma","year":"2018","unstructured":"Sharma P, Kaur S, Kaur R, Kaur M, Kaur S. Proteinaceous secretory metabolites of probiotic human commensal Enterococcus hirae 20c, E. faecium 12a and L12b as antiproliferative agents against cancer cell lines. Front Microbiol. 2018;9:948.","journal-title":"Front Microbiol"},{"key":"1396_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02086-5","volume":"21","author":"P Sharma","year":"2021","unstructured":"Sharma P, et al. Anticancer and antimicrobial potential of enterocin 12a from Enterococcus faecium. BMC Microbiol. 2021;21:39.","journal-title":"BMC Microbiol"},{"key":"1396_CR52","doi-asserted-by":"publisher","first-page":"7423","DOI":"10.3892\/mmr.2017.7577","volume":"16","author":"Z Shi","year":"2017","unstructured":"Shi Z, et al. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray. Mol Med Rep. 2017;16:7423\u201331.","journal-title":"Mol Med Rep"},{"key":"1396_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-021-00295-2","volume":"27","author":"A Sipos","year":"2021","unstructured":"Sipos A, et al. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Mol Med. 2021;27:33.","journal-title":"Mol Med"},{"key":"1396_CR54","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.cmet.2021.11.010","volume":"33","author":"M St Paul","year":"2021","unstructured":"St Paul M, et al. Coenzyme A fuels T cell anti-tumor immunity. Cell Metab. 2021;33:2415\u2013e24272416.","journal-title":"Cell Metab"},{"key":"1396_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/8828367","volume":"2024","author":"C Tang","year":"2024","unstructured":"Tang C, et al. Cryptotanshinone inhibits bladder cancer cell malignant progression in a lipopolysaccharide-induced inflammatory microenvironment through NLRP3 inhibition. Mediators Inflamm. 2024;2024:8828367.","journal-title":"Mediators Inflamm"},{"key":"1396_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ygyno.2024.07.690","volume":"190","author":"XR Tee","year":"2024","unstructured":"Tee XR, et al. Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations. Gynecol Oncol. 2024;190:18\u201327.","journal-title":"Gynecol Oncol"},{"key":"1396_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ijc.1448","volume":"94","author":"Y Terao","year":"2001","unstructured":"Terao Y, et al. Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells. Int J Cancer. 2001;94:257\u201367.","journal-title":"Int J Cancer"},{"key":"1396_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6574491","volume":"2021","author":"R Wang","year":"2021","unstructured":"Wang R, Bu W, Yang Y. Identification of metabolism-related genes influencing prognosis of multiple myeloma patients. J Healthc Eng. 2021;2021:6574491.","journal-title":"J Healthc Eng"},{"key":"1396_CR59","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1038\/s41388-023-02695-6","volume":"42","author":"Z Wang","year":"2023","unstructured":"Wang Z, et al. METTL1\/WDR4-mediated tRNA m(7)G modification and mRNA translation control promote oncogenesis and doxorubicin resistance. Oncogene. 2023;42:1900\u201312.","journal-title":"Oncogene"},{"key":"1396_CR60","doi-asserted-by":"publisher","first-page":"110225","DOI":"10.1016\/j.isci.2024.110225","volume":"27","author":"C Wang","year":"2024","unstructured":"Wang C, et al. METTL1-modulated LSM14A facilitates proliferation and migration in glioblastoma via the stabilization of DDX5. iScience. 2024;27:110225.","journal-title":"iScience"},{"key":"1396_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107364","author":"Y Xu","year":"2024","unstructured":"Xu Y, et al. Decoding the microbiota metabolome in hepatobiliary and pancreatic cancers: pathways to precision diagnostics and targeted therapeutics. Pharmacol Res. 2024. https:\/\/doi.org\/10.1016\/j.phrs.2024.107364.","journal-title":"Pharmacol Res"},{"key":"1396_CR62","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12282-024-01579-1","volume":"31","author":"PJ Yang","year":"2024","unstructured":"Yang PJ, Tsai EM, Hou MF, Lee YJ, Wang TN. Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors. Breast Cancer. 2024a;31:659\u201370.","journal-title":"Breast Cancer"},{"key":"1396_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.05.017","author":"Q Yang","year":"2024","unstructured":"Yang Q, et al. Bckdk modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism. Mol Ther. 2024b. https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.017.","journal-title":"Mol Ther"},{"key":"1396_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1173424","volume":"13","author":"Y Yi","year":"2023","unstructured":"Yi Y, et al. LC-MS-based serum metabolomics analysis for the screening and monitoring of colorectal cancer. Front Oncol. 2023;13:1173424.","journal-title":"Front Oncol"},{"issue":"1","key":"1396_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02777-z","volume":"42","author":"M Zhang","year":"2023","unstructured":"Zhang M, et al. P300\/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC. J Exp Clin Cancer Res. 2023;42(1):215.","journal-title":"J Exp Clin Cancer Res"},{"key":"1396_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111288","volume":"121","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Exploring the role of m7G modification in cancer: mechanisms, regulatory proteins, and biomarker potential. Cell Signal. 2024;121:111288.","journal-title":"Cell Signal"},{"key":"1396_CR67","doi-asserted-by":"publisher","first-page":"6230","DOI":"10.1021\/acs.jcim.4c00802","volume":"64","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Jin J, Gao W, Qiao J, Wei L. Moss-m7G: a motif-based interpretable deep learning method for RNA N7-methlguanosine site prediction. J Chem Inf Model. 2024;64:6230\u201340.","journal-title":"J Chem Inf Model"},{"key":"1396_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.972341","volume":"13","author":"P Zheng","year":"2022","unstructured":"Zheng P, Li N, Zhan X. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: novel prediction model of prognosis. Front Endocrinol (Lausanne). 2022;13:972341.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1396_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38031-2","volume":"9","author":"B Zhou","year":"2019","unstructured":"Zhou B, et al. The biodiversity composition of microbiome in ovarian carcinoma patients. Sci Rep. 2019;9:1691.","journal-title":"Sci Rep"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01396-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01396-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01396-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:04:23Z","timestamp":1769069063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-025-01396-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1396"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01396-y","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Researches involving human participants have been performed in accordance with the Declaration of Helsinki and must have been approved by ethics committee of Xiangya Third Hospital of Central South University (K25093). Informed consent to participate in the study was obtained from participants. Animal experiments were performed in accordance with the ARRIVE reporting guidelines and were approved by the IRB of Xiangya Third Hospital of Central South University (2023-S683).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}